TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
WVE

Wave Life Sciences Ltd

Healthcare · Biotechnology

3.80$ -4.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Wave Life Sciences Ltd (WVE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 558 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WVE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
180 165 152 226 202 182 150 354 325 296 431 386 347 284 239 204 310 279 243 206 201 207 167 213 182 146 267 230 200 275 235 209 359 352 288 252 241 638 584 558
172 152 133 201 174 150 118 268 233 202 315 290 250 185 150 147 258 230 195 159 158 163 124 160 131 99 220 185 159 235 197 172 325 320 258 224 215 615 561 508
169 150 129 197 168 143 110 241 210 175 288 253 209 147 121 94 216 184 149 144 124 151 62 123 97 88 208 173 140 200 181 154 311 302 243 208 196 602 545 368
169 150 129 197 168 143 110 241 210 175 288 253 209 147 121 94 216 184 149 144 124 151 112 148 122 88 208 173 140 200 181 154 311 302 243 208 196 602 545 491
2.5 0.2 – – – 1.0 1.0 15 10 10 10 20 20 20 19 30 30 30 30 0.0 23 0.0 – – – 0.0 – – 7.0 21 0.0 1.3 0.0 1.4 1.4 1.6 10 1.3 0.0 0.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0 -0.1 0.0 – – – – 9.6 10.0 6.5 8.0 10 10 – 7.6 – – – – – – – 7.5 0.0 – 0.0 – – – – – – – –
6.7 8.6 14 21 25 27 29 32 38 40 59 57 56 54 53 50 31 29 27 41 39 22 39 20 46 17 16 15 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
29 30 34 38 36 42 40 214 218 223 234 225 232 213 210 201 202 189 190 185 171 175 160 182 178 191 302 282 240 235 210 204 209 143 117 113 117 112 72 105
11 12 14 16 15 20 16 44 126 130 132 124 133 118 119 110 110 121 49 47 32 64 58 64 64 72 133 140 100 186 166 173 171 111 87 87 86 95 50 51
0.1 0.1 0.4 0.3 0.7 0.0 1.0 1.5 2.0 2.3 2.9 3.0 3.1 3.2 3.4 3.5 3.6 3.7 3.8 4.0 4.1 5.0 5.1 4.4 4.9 5.5 6.1 6.3 6.5 6.7 6.9 7.2 7.4 7.6 7.9 8.1 8.4 8.4 8.3 3.5
3.8 4.9 7.4 8.0 4.7 7.6 8.0 7.2 12 13 15 11 20 9.1 16 14 9.7 14 13 8.7 7.4 7.3 9.9 11 16 17 12 12 13 13 12 18 13 16 14 15 14 16 19 20
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 32 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
151 135 117 189 166 140 110 139 107 73 197 160 115 72 29 3.4 108 91 53 22 30 32 7.8 31 3.4 -45 -35 -52 -40 40 25 4.4 150 210 172 139 125 526 512 454
-72 -90 -111 -136 -162 -193 -228 -264 -302 -340 -384 -426 -477 -533 -581 -621 -654 -683 -726 -764 -771 -806 -843 -885 -924 -967 -995 -1,016 -1,009 -1,025 -1,056 -1,089 -1,151 -1,122 -1,169 -1,219 -1,273 -1,326 -1,352 -1,422
23 24 24 27 28 28 28 29 29 33 33 34 34 34 34 35 38 49 49 50 51 57 61 66 94 94 102 105 107 110 129 130 133 172 163 164 168 180 200 202

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?